Perspectives
Carve-in evidence continues to build
Linking pharmacy and medical benefits in one contract is better for the bottom line.
June 1, 2020Related news
Perspectives
January 24, 2023
Traditional Drug Pipeline Update: January 2023
This monthly pipeline wrap-up provides a review of newly approved traditional drugs, recent…
Perspectives
January 24, 2023
Specialty Pipeline Monthly Update: January 2023
This monthly pipeline wrap-up provides a review of newly approved specialty drugs, recent…
Perspectives
January 13, 2023
February 2023 decisions expected from the FDA
At Prime Therapeutics (Prime), we’ve positioned ourselves to best prepare our clients to…